Aziyo Biologics, Inc., a commercial-stage biotechnology company based in Silver Spring, Maryland, specializes in drug-eluting biologic technologies for device implantation and tissue reconstruction. The company, which went public in 2020, develops products like CanGaroo Envelope for cardiac device stabilization and SimpliDerm for breast reconstruction post-mastectomy.
Elutia (ELUT) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Elutia's actual EPS was -$1.13, missing the estimate of -$0.34 per share, resulting in a -235.71% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
